Registration - In-house Corporation

Resilience Biotechnologies, Inc. / Julie Henao, Vice President / General Manager

Registration Information

In-house Corporation name: Resilience Biotechnologies, Inc.
Responsible Officer Name: Julie Henao, Vice President / General Manager
Responsible Officer Change History
Initial registration start date: 2021-02-24
Registration status: Active
Registration Number: 962375-368948

Associated Communications

Total Number of Communication Reports: 1

Monthly communication reports in the last 6 months: 0

Version 1 of 12 (2021-02-24 to 2021-06-28)

Registration versions:

Version 1 of 12 (2021-02-24 to 2021-06-28)

Lobbying Information

Subject Matters

Economic Development
Employment and Training
Energy
Environment
Government Procurement
Health
Industry
Infrastructure
Intellectual Property
Internal Trade
International Development
International Relations
International Trade
Labour
National Security/Security
Privacy and Access to Information
Regional Development
Research and Development
Science and Technology
Taxation and Finance

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Seeking funding from the Strategic Innovation Fund to allow for the construction of facilities to advance Canada’s vaccine and biomanufacturing capabilities.

Policies or Program

Engage with the federal government on building Canada's vaccine and biomanufacturing ecosystem.

Communication Techniques

Written communication
Oral communication

Government Institutions

Business Development Bank of Canada (BDC)
Employment and Social Development Canada (ESDC)
Export Development Canada (EDC)
Finance Canada (FIN)
Health Canada (HC)
House of Commons
Infrastructure Canada (INFC)
Innovation, Science and Economic Development Canada (ISED)
National Research Council (NRC)
Natural Sciences and Engineering Research Council (NSERC)
Prime Minister's Office (PMO)
Public Health Agency of Canada (PHAC)

In-house Corporation Details

Description of activities

Resilience Biotechnologies (RBI), formerly Therapure Biopharma, is a wholly owned subsidiary of National Resilience, Inc. RBI is an Ontario-based Contract Development and Manufacturing Organization (CDMO) specializing in the development and manufacturing of complex biologics. RBI’s mission is to support for Canadian vaccine and therapeutics production and serve as a long-term partner for Canadian pharmaceutical manufacturing.

Responsible officer name and position during the period of this registration

Safa'a Al-Rais, Chief Operating Officer

Government funding

End date of the last completed financial year: 2020-12-31

List of Government Funding
Government Institution	Funding Received in Last Financial Year	Funding Expected in Current Financial Year
National Research Council (NRC)	$0.00	Yes

In-house Corporation Contact Information

Address:
2585 Meadowpine Blvd.
Mississauga, ON L5N 8H9
Canada

Telephone number: 905-286-6200

Parent Company Information

National Resilience, Inc.
- 9310 Athena Circle, Suite 130
  La Jolla, CA 92037
  United States of America

Subsidiary Beneficiary Information

Resilience Biotechnologies, Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Safa'a Al-Rais, Chief Operating Officer | No public offices held
Alex Farrow, Senior Finance Manager | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

No lobbyists added

Resilience Biotechnologies, Inc.

The following names have been used on or after July 2, 2008

Name	From	To
Resilience Biotechnologies, Inc.	2021-02-24	current

Resilience Biotechnologies, Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Julie Henao	2025-10-20	Current
Sankalp Vashishtha	2022-07-29	2025-10-20
Safa'a Al-Rais	2021-02-24	2022-07-29

Date Modified:: 2026-05-11

Search and menus

Language selection

Registration - In-house Corporation

Resilience Biotechnologies, Inc. / Julie Henao, Vice President / General Manager

Registration Information

Associated Communications

Version 1 of 12 (2021-02-24 to 2021-06-28)

Version 1 of 12 (2021-02-24 to 2021-06-28)

Subject Matters

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Policies or Program

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties